| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 7.001 | 7.639 | 6.574 | 4.461 | 2.313 | 3.691 | 285 | 0 | 0 | 482 |
| Total Income - EUR | 7.001 | 7.639 | 9.610 | 4.461 | 2.313 | 3.691 | 689 | 0 | 0 | 483 |
| Total Expenses - EUR | 2.586 | 5.340 | 4.673 | 4.732 | 4.048 | 3.144 | 2.667 | 4.096 | 924 | 1.014 |
| Gross Profit/Loss - EUR | 4.415 | 2.299 | 4.937 | -271 | -1.735 | 547 | -1.978 | -4.096 | -924 | -531 |
| Net Profit/Loss - EUR | 4.205 | 2.070 | 4.649 | -405 | -1.804 | 436 | -1.998 | -4.096 | -924 | -531 |
| Employees | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 0 |
Check the financial reports for the company - Prestige Medfarm Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 156 | 6 | 0 | 34.025 | 32.516 | 31.065 | 29.561 | 28.835 | 27.932 | 26.965 |
| Current Assets | 16.613 | 19.141 | 21.475 | 12.891 | 9.498 | 10.394 | 9.560 | 1.049 | 704 | 653 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 14.805 | 18.629 | 19.457 | 10.077 | 8.846 | 8.645 | 8.454 | 0 | 0 | 0 |
| Cash | 1.808 | 512 | 2.018 | 2.814 | 652 | 1.748 | 1.106 | 1.049 | 704 | 653 |
| Shareholders Funds | 13.185 | 15.121 | 19.514 | 18.751 | 16.583 | 16.705 | 14.336 | 10.285 | 9.330 | 8.746 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 3.584 | 4.027 | 1.962 | 28.165 | 25.431 | 24.754 | 24.784 | 19.598 | 19.306 | 18.871 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8621
|
|||||||||
Comments - Prestige Medfarm Srl